Skip to main content
logo
HOCHTIEF Aktiengesellschaft (HOCFF)
OTCMKTS · Delayed Price · Currency is USD
229.25
+4.25 (1.89%)
Aug 6, 2025, 1:57 PM EDT

Revance Therapeutics Revenue

HOCHTIEF Aktiengesellschaft had revenue of 9.45B EUR in the quarter ending June 30, 2025, with 19.73% growth. This brings the company's revenue in the last twelve months to 37.02B, up 25.95% year-over-year. In the year 2024, HOCHTIEF Aktiengesellschaft had annual revenue of 33.30B with 19.98% growth.

Revenue (ttm)
37.02B EUR
Revenue Growth
+25.95%
P/S Ratio
0.39
Revenue / Employee
726.43K EUR
Employees
50,961
Market Cap
17.15B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202433.30B5.55B19.98%
Dec 31, 202327.76B1.54B5.86%
Dec 31, 202226.22B4.84B22.65%
Dec 31, 202121.38B-1.58B-6.87%
Dec 31, 202022.95B-2.90B-11.21%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Thai Airways International Public Company5.55B
Kuber Resources5.07M
Steel Partners Holdings L.P.2.05B
Entrepreneur Universe Bright Group4.98M
Siem Industries224.73M
Paul Mueller Company264.04M
Mestek299.77M
Scope Industries77.00M
Revenue Rankings

HOCHTIEF Aktiengesellschaft News

More News